UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020803
Receipt number R000024015
Scientific Title A method comparison study of FeNO measurements, between the NOA280i and the NIOX VERO
Date of disclosure of the study information 2016/02/01
Last modified on 2019/08/02 18:49:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A method comparison study of FeNO measurements, between the NOA280i and the NIOX VERO

Acronym

A method comparison study of FeNO measurements, between the NOA280i and the NIOX VERO

Scientific Title

A method comparison study of FeNO measurements, between the NOA280i and the NIOX VERO

Scientific Title:Acronym

A method comparison study of FeNO measurements, between the NOA280i and the NIOX VERO

Region

Japan


Condition

Condition

asthma

Classification by specialty

Pneumology Clinical immunology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether FeNO values obtained with the NIOX VERO are comparable with the NOA280i.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Coefficient calculated for FeNO values obtained with the NOA280i and the NIOX VERO

Key secondary outcomes

Bland-Altman plot used to assess agreement between FeNO values obtained with the NOA280i and the NIOX VERO


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

FeNO values are measured in all participants, using both the NIOX VERO and the NOA280i.
Three acceptable measurement is performed with each device.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Asthmatic patients who give written informed consent to this study.

Key exclusion criteria

Those who need oxygenation.
Those who can not perform technically adequate measurements.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Taisuke
Middle name
Last name Akamatsu

Organization

Shizuoka General Hospital

Division name

Pneumology

Zip code

420-8527

Address

4-27-1 Kita-ando, Shizuoka city, Shizuoka, Japan

TEL

054-247-6111

Email

taisuke-akamatsu@i.shizuoka-pho.jp


Public contact

Name of contact person

1st name Taisuke
Middle name
Last name Akamatsu

Organization

Shizuoka General Hospital

Division name

Pneumology

Zip code

420-8527

Address

4-27-1 Kita-ando, Shizuoka city, Shizuoka, Japan

TEL

054-247-6111

Homepage URL


Email

taisuke-akamatsu@i.shizuoka-pho.jp


Sponsor or person

Institute

Shizuoka General Hospital

Institute

Department

Personal name



Funding Source

Organization

Shizuoka General Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Ethics Committee, Shizuoka General Hospital

Address

4-27-1 Kita Ando Aoi-ku, Shizuoka City Japan

Tel

054-247-6111

Email

chiken-sougou@shizuoka-pho.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

静岡県立総合病院


Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 01 Day


Related information

URL releasing protocol

https://www.clinicalkey.jp/#!/content/playContent/1-s2.0-S1081120617305938?returnurl=https:%2F%2Flin

Publication of results

Published


Result

URL related to results and publications

https://www.clinicalkey.jp/#!/content/playContent/1-s2.0-S1081120617305938?returnurl=https:%2F%2Flin

Number of participants that the trial has enrolled

107

Results

FeNO levels measured using the NIOX VERO (mean +- SD 53.4 +- 38.9 ppb) were significantly higher than those using the NOA 280i (41.7 +- 33.2 ppb; P < .0001). However, there was a significant correlation between FeNO levels measured with the two devices (r = 0.946, P < .0001). The Bland-Altman plot showed a moderate degree of agreement between the 2 devices; the mean inter-device difference was 11.7 ppb (95% limits of agreement -13.5 and 37.0 ppb).

Results date posted

2019 Year 08 Month 02 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Subjects included 107 adult patients with bronchial asthma (51 men and 56 women; 59 nonsmokers, 46 ex-smokers, and 2 current smokers; 75 with and 32 without atopy; mean age 60 years, mean body mass index 24.0 kg/m 2 , and mean predicted percentage of forced expiratory volume in 1 second 82.6%).

Participant flow

There were no excluded patients.

Adverse events

No troubles.

Outcome measures

- Coefficient calculated for FeNO values obtained with the NOA280i and the NIOX VERO
- Bland-Altman plot used to assess agreement between FeNO values obtained with the NOA280i and the NIOX VERO
(See Results)

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 12 Month 01 Day

Date of IRB

2015 Year 12 Month 27 Day

Anticipated trial start date

2016 Year 02 Month 01 Day

Last follow-up date

2017 Year 01 Month 31 Day

Date of closure to data entry

2017 Year 01 Month 31 Day

Date trial data considered complete

2017 Year 01 Month 31 Day

Date analysis concluded

2017 Year 02 Month 10 Day


Other

Other related information



Management information

Registered date

2016 Year 01 Month 30 Day

Last modified on

2019 Year 08 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024015


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name